SAMUEL SINGER, MD
Radiology at York Ave, New York, NY

General Surgery

Adrenalectomy, Appendectomy, Open, Colectomy, Cystectomy, Destruction or Excision of Vaginal Lesions, Excision of Tumor of Stomach, Excision, Shaving, or Destruction of Skin and Subcutaneous Tissue (incl. Mohs Micrographic Surgery), Tissue Transfer, Hepatectomy, Incisional/Ventral Hernia Repair, Open, Inguinal Hernia Repair, Open, Intestinal Transplant (incl. Enterectomy), Laparotomy, Lymph Node Biopsy or Excision, Mastectomy, Orchiectomy, Pancreatectomy (incl. Pancreas Transplant & Whipple Procedure), Peripheral Artery Bypass Procedures, Port Placements or Replacements, Removal of Reproductive Organs (Hysterectomy, Oophorectomy, Salpingectomy, Salpingo-Oophorectomy, Resection of Peritoneal Malignancy), Removal or Destruction of Rectal or Intestinal Tumor (incl. Colonoscopy, Proctosigmoidoscopy, Sigmoidoscopy & Control of Hemorrhage), Renal Transplant and Nephrectomy, Splenectomy, Splenectomy and Splenorrhaphy, Thoracoscopic Wedge Resection, Video-Assisted Thoracic Surgery (VATS) or Thoracotomy

Adrenal Gland Cancer, Breast Cancer, Carcinoma in Situ, Cholecystitis and Gallstones, Colorectal Cancer, Crohn's Disease (Regional Enteritis), Diaphragmatic/Hiatal Hernia, Hyperparathyroidism, Incisional Hernia, Inguinal Hernia, Intestinal Obstruction, Lipomas, Liver Cancer, Lung Cancer, Neuroendocrine Tumors, Pancreatic Cancer, Peripheral Arterial Aneurysm and Dissection, Peripheral Vascular Disease (PAD, PVD), Phlebitis and Thrombophlebitis, Secondary Malignancies, Soft Tissue Sarcoma, Stomach and Small Intestine Cancer, Testicular Cancer, Ulcerative Colitis, Umbilical Hernia, Varicose Veins, Ventral Hernia

General Surgery, 2010

Healthgrades Honor Roll

English

I am a surgical oncologist who specializes in the diagnosis and treatment of soft tissue sarcoma. I have a special expertise and experience in the multi-modality treatment of soft tissue sarcoma, which includes performing carefully planned limb-sparing surgery that in certain situations is combined with radiation or chemotherapy. At MSKCC, I work closely with a multidisciplinary team of soft tissue pathologists, medical oncologists, and radiation oncologists to provide the best treatment plan for each individual patient. Soft tissue sarcomas are relatively uncommon, especially when considered as individual histological subtypes (of which there are more than 50). Treatment outcome generally is improved significantly when patients are managed by a multidisciplinary team of experts in a tertiary center of excellence that treats a large volume of patients with sarcoma. MSKCC's team of soft tissue sarcoma experts likely has the largest experience with these tumors of any medical group in the world. In addition to my clinical sarcoma practice, I have initiated an extensive laboratory research effort designed to develop new methods to improve the diagnosis of sarcoma and increase the accuracy of predicting treatment outcome and survival for individual patients. These new methods will eventually enable the treating physician to more accurately predict a patient's response to treatment (such as radiation or chemotherapy). I have also been actively involved in developing and designing new targeted therapies for soft tissue sarcoma such as: PPAR gamma ligands for the treatment of liposarcoma; Gleevec therapy for gastrointestinal stromal sarcoma; and anti-angiogenesis therapy for soft tissue sarcoma.

Surgery, Surgical Oncology, Hematology & Oncology, Medical Oncology

MSKCC Surgery Group
1275 York Ave, New York, NY 10065

Harvard University(1982)

Retired at Retired

Computer Software

Neurology, Surgery, Medical Oncology

Memorial Sloan-Kettering
1275 York Ave, New York, NY 10065

Yeshiva University (2007)

Internal Medicine

English